Healthcare Global Enterprises Ltd Analyst Rating
based on 10 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 10 analysts offering long term price targets for Healthcare Global Enterprises Ltd. An average target of ₹506
Source: S&P Global Market Intelligence
Healthcare Global Enterprises Ltd Share analysis
Healthcare Global Enterprises Ltd price forecast by 10 analysts
Upside of1.31%
High
₹600
Target
₹506.00
Low
₹342
Healthcare Global Enterprises Ltd target price ₹506, a slight upside of 1.31% compared to current price of ₹494.2. According to 10 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Healthcare Global Enterprises Ltd revenue growth forecast
Expected growth rate Q1, FY2027:54.70%
Forecast
Actual
Including amortisation and stock based compensations
Healthcare Global Enterprises Ltd EPS growth forecast
EPS estimate Q1, FY2027:306.36%
Forecast
Actual
Source: S&P Global Market Intelligence
Healthcare Global Enterprises Ltd Performance
Day's Low
Day's High
₹491.25Day's Price Range₹50552 Week's Low
52 Week's High
₹31452-Week Price Range₹548
| Returns % | |
| 1 Month Return | -5.99 % |
| 3 Month Return | + 16.93 % |
| 1 Year Return | + 40.69 % |
| Market Stats | |
| Previous Close | ₹499.45 |
| Open | ₹493.15 |
| Volume | 77.09K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹6,962.47Cr |
Healthcare Global Enterprises Ltd Key Statistics
| P/E Ratio | 121.82 |
| PEG Ratio | 84.6 |
| Market Cap | ₹6,962.47 Cr |
| P/B Ratio | 3.96 |
| EPS | 2.97 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | 3.22 |
Healthcare Global Enterprises Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹6,962.47 Cr | 67.74% | 0.70 | ₹41 Cr | ₹1,907 Cr | |
| NA | ₹1,194.54 Cr | 76.56% | 0.68 | NA | NA | |
| NA | ₹73.99 Cr | 31.49% | 0.56 | -₹2 Cr | ₹39 Cr | |
| NA | ₹51.98 Cr | -11.35% | 0.55 | NA | NA | |
| NA | ₹41.90 Cr | 174% | 0.62 | ₹3 Cr | ₹22 Cr |
Healthcare Global Enterprises Ltd Mutual Fund Holdings
About Healthcare Global Enterprises Ltd
Established in 1998, HCG expanded its operations in 2016 with a successful Initial Public Offering (IPO) and launched advanced cancer centres in Baroda and Visakhapatnam. Later, in 2017, it acquired a majority stake in Cancer Care Kenya, and launched its first cancer centre in Kanpur with 90 dedicated beds. It is also setting up hospitals with high end linear accelerators in Kolkata and Nashik. HCG has been dedicated to delivering quality medical care across diagnosis and treatment, and its latest technologies like Robotic Surgery and Tomotherapy Treatment System are paving the way for a better tomorrow.
Share Price: ₹494.20 per share as on 20 Jan, 2025 10:04 AM
Market Capitalisation: ₹6,962.47Cr as of today
Revenue: ₹552.47Cr as on September 2024 (Q3 24)
Net Profit: ₹20.68Cr as on September 2024 (Q3 24)
Listing date: 30 Mar, 2016
Chairperson Name: BASAVALINGA AJAIKUMAR SADASHIVAIAH
| Organisation | Healthcare Global Enterprises Ltd |
| Headquarters | Bengaluru |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Healthcare Global Enterprises Ltd
Healthcare Global Enterprises Faces Investor Exit Rumors - 02 Jan, 2025
Healthcare Global Enterprises Ltd is reportedly facing potential exits from some investors, though no actions have been confirmed. The stock saw a 34% return in 2024, with Axis Securities projecting an additional 18% gain in 2025, targeting a price of ₹575.KKR's Acquisition Plans and HCG's Strong Performance - 04 Dec, 2024
KKR is nearing a deal to acquire a 60.36% stake in Healthcare Global Enterprises (HCG) from CVC. HCG also announced a partnership with Accenture for AI-driven cancer research and reported a significant increase in net profit and revenue for Q2 FY25.
Insights on Healthcare Global Enterprises Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 4 quarters, 475.94 Cr → 564.67 Cr (in ₹), with an average increase of 5.5% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 12.08 Cr → 17.99 Cr (in ₹), with an average increase of 32.9% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 12.83% to 13.06% in Dec 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, HCG stock has moved up by 0.1%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 8.94% to 10.04% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 60.0% return, outperforming this stock by 27.4%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 71.23% of holdings in Dec 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 173.0% return, outperforming this stock by 75.8%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 4.29% to 2.77% in Dec 2024 quarter
Healthcare Global Enterprises Ltd Financials
Index Inclusions
Healthcare Global Enterprises Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.23% | ||
| Foreign Institutions | 2.77% | ||
| Mutual Funds | 10.04% | 12.23 | |
| Retail Investors | 13.06% | 1.82 | |
| Others | 2.9% | 7.40 |
Healthcare Global Enterprises Ltd Key Indicators
Healthcare Global Enterprises Ltd Valuation
Healthcare Global Enterprises Ltd in the last 5 years
Lowest (-514.24x)
November 27, 2018
Industry (97.73x)
January 17, 2025
Today (121.82x)
January 17, 2025
Highest (201.31x)
July 2, 2018
Healthcare Global Enterprises Ltd Earnings and Dividends
Healthcare Global Enterprises Ltd Earnings Results
Healthcare Global Enterprises Ltd’s net profit jumped 32.57% since last year same period to ₹17.99Cr in the Q2 2024-2025. On a quarterly growth basis, Healthcare Global Enterprises Ltd has generated 48.92% jump in its net profits since last 3-months.
Read More about Earnings Results
Healthcare Global Enterprises Ltd Technicals Summary
Bearish
Neutral
Bullish
Healthcare Global Enterprises Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Healthcare Global Enterprises Ltd
Healthcare Global Enterprises Ltd share price today stands at ₹494.2, Open. ₹493.15 ; Previous Close. ₹499.45 ; High. ₹505 ; Low. ₹491.25 ; 52 Week High. ₹548 ; 52 Week Low: ₹314.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Healthcare Global Enterprises Ltd shares.
Healthcare Global Enterprises Ltd is listed on NSE
Healthcare Global Enterprises Ltd is listed on BSE
- Today’s highest price of Healthcare Global Enterprises Ltd is ₹505.
- Today’s lowest price of Healthcare Global Enterprises Ltd is ₹491.25.
PE Ratio of Healthcare Global Enterprises Ltd is 121.82
PE ratio = Healthcare Global Enterprises Ltd Market price per share / Healthcare Global Enterprises Ltd Earnings per share
Today’s traded volume of Healthcare Global Enterprises Ltd(HCG) is 77.09K.
Today’s market capitalisation of Healthcare Global Enterprises Ltd(HCG) is ₹6962.47Cr.
| Healthcare Global Enterprises Ltd(HCG | Price |
|---|---|
52 Week High | ₹548 |
52 Week Low | ₹314 |
Healthcare Global Enterprises Ltd(HCG) share price is ₹494.2. It is down -9.82% from its 52 Week High price of ₹548
Healthcare Global Enterprises Ltd(HCG) share price is ₹494.2. It is up 57.39% from its 52 Week Low price of ₹314
| Healthcare Global Enterprises Ltd(HCG | Returns |
|---|---|
1 Day Returns | -5.25% |
1 Month Returns | -5.99% |
3 Month Returns | 16.93% |
1 Year Returns | 40.69% |